These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
765 related articles for article (PubMed ID: 26431277)
1. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway. Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277 [TBL] [Abstract][Full Text] [Related]
2. Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility. Wang Z; Wu Y; Wang H; Zhang Y; Mei L; Fang X; Zhang X; Zhang F; Chen H; Liu Y; Jiang Y; Sun S; Zheng Y; Li N; Huang L Proc Natl Acad Sci U S A; 2014 Jan; 111(1):E89-98. PubMed ID: 24367099 [TBL] [Abstract][Full Text] [Related]
3. A feed forward loop enforces YAP/TAZ signaling during tumorigenesis. Gill MK; Christova T; Zhang YY; Gregorieff A; Zhang L; Narimatsu M; Song S; Xiong S; Couzens AL; Tong J; Krieger JR; Moran MF; Zlotta AR; van der Kwast TH; Gingras AC; Sicheri F; Wrana JL; Attisano L Nat Commun; 2018 Aug; 9(1):3510. PubMed ID: 30158528 [TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 Pathways. Karvonen H; Barker H; Kaleva L; Niininen W; Ungureanu D Cells; 2019 Aug; 8(8):. PubMed ID: 31382410 [TBL] [Abstract][Full Text] [Related]
5. Deregulation of the Hippo pathway in mouse mammary stem cells promotes mammary tumorigenesis. Li H; Gumbiner BM Mamm Genome; 2016 Dec; 27(11-12):556-564. PubMed ID: 27601049 [TBL] [Abstract][Full Text] [Related]
6. RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo-Yap Pathway. Guo PD; Lu XX; Gan WJ; Li XM; He XS; Zhang S; Ji QH; Zhou F; Cao Y; Wang JR; Li JM; Wu H Cancer Res; 2016 Jul; 76(13):3813-25. PubMed ID: 27325643 [TBL] [Abstract][Full Text] [Related]
7. Regulation of the Hippo/YAP axis by CXCR7 in the tumorigenesis of gastric cancer. Wang T; Wang D; Sun Y; Zhuang T; Li X; Yang H; Zang Y; Liu Z; Yang P; Zhang C; Cui J; Fu M; Zhang S; Su P; Li Z; Zhu J; Ding Y J Exp Clin Cancer Res; 2023 Nov; 42(1):297. PubMed ID: 37950281 [TBL] [Abstract][Full Text] [Related]
8. Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. Rashidian J; Le Scolan E; Ji X; Zhu Q; Mulvihill MM; Nomura D; Luo K Sci Signal; 2015 Feb; 8(363):ra14. PubMed ID: 25670202 [TBL] [Abstract][Full Text] [Related]
9. Arhgef7 promotes activation of the Hippo pathway core kinase Lats. Heidary Arash E; Song KM; Song S; Shiban A; Attisano L EMBO J; 2014 Dec; 33(24):2997-3011. PubMed ID: 25425573 [TBL] [Abstract][Full Text] [Related]
10. A kinome-wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion. Nouri K; Azad T; Lightbody E; Khanal P; Nicol CJ; Yang X FASEB J; 2019 Nov; 33(11):12487-12499. PubMed ID: 31431076 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway. Chen M; Wang M; Xu S; Guo X; Jiang J Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204 [TBL] [Abstract][Full Text] [Related]
12. Stearoyl-CoA-desaturase-1 regulates gastric cancer stem-like properties and promotes tumour metastasis via Hippo/YAP pathway. Gao Y; Li J; Xi H; Cui J; Zhang K; Zhang J; Zhang Y; Xu W; Liang W; Zhuang Z; Wang P; Qiao Z; Wei B; Chen L Br J Cancer; 2020 Jun; 122(12):1837-1847. PubMed ID: 32350414 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells. You B; Yang YL; Xu Z; Dai Y; Liu S; Mao JH; Tetsu O; Li H; Jablons DM; You L Oncotarget; 2015 Feb; 6(6):4357-68. PubMed ID: 25738359 [TBL] [Abstract][Full Text] [Related]
14. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway. Zhou PJ; Xue W; Peng J; Wang Y; Wei L; Yang Z; Zhu HH; Fang YX; Gao WQ J Exp Clin Cancer Res; 2017 Oct; 36(1):139. PubMed ID: 29017577 [TBL] [Abstract][Full Text] [Related]
15. Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1. Si Y; Ji X; Cao X; Dai X; Xu L; Zhao H; Guo X; Yan H; Zhang H; Zhu C; Zhou Q; Tang M; Xia Z; Li L; Cong YS; Ye S; Liang T; Feng XH; Zhao B Cancer Res; 2017 Sep; 77(18):4868-4880. PubMed ID: 28754671 [TBL] [Abstract][Full Text] [Related]
16. Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1. Fan R; Kim NG; Gumbiner BM Proc Natl Acad Sci U S A; 2013 Feb; 110(7):2569-74. PubMed ID: 23359693 [TBL] [Abstract][Full Text] [Related]
17. Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner. Liu Y; Wang G; Yang Y; Mei Z; Liang Z; Cui A; Wu T; Liu CY; Cui L Oncogene; 2016 May; 35(21):2789-800. PubMed ID: 26387538 [TBL] [Abstract][Full Text] [Related]
18. [Research advances in the role of the Hippo-YAP/TAZ signaling pathway in primary liver cancer]. Guo LW; Shao GL Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):878-880. PubMed ID: 29325286 [TBL] [Abstract][Full Text] [Related]
19. OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ. Zhang Z; Du J; Wang S; Shao L; Jin K; Li F; Wei B; Ding W; Fu P; van Dam H; Wang A; Jin J; Ding C; Yang B; Zheng M; Feng XH; Guan KL; Zhang L Mol Cell; 2019 Jan; 73(1):7-21.e7. PubMed ID: 30472188 [TBL] [Abstract][Full Text] [Related]
20. Hippo signaling dysfunction induces cancer cell addiction to YAP. Han H; Yang B; Nakaoka HJ; Yang J; Zhao Y; Le Nguyen K; Bishara AT; Mandalia TK; Wang W Oncogene; 2018 Dec; 37(50):6414-6424. PubMed ID: 30068939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]